Short Bowel Syndrome Market

Home Healthcare And Pharmaceutical Short Bowel Syndrome Market

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (GLP-2, Growth Hormone, Glutamine); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: August 2023
Report ID: BWC23628
Available Format: PDF
Page: 400

Report Overview

Increasing prevalence of short bowel syndrome (SBS) and the growing demand for SBS drugs due to the high cost of parenteral nutrition are projected to propel the expansion of the global short bowel syndrome market during the forecast period between 2023 and 2029.

Global Short Bowel Syndrome Market - Industry Trends & Forecast Report, 2029

Global short bowel syndrome market size was estimated at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, the size of global short bowel syndrome market is projected to grow at a CAGR of 14.05% reaching a value of USD 2,035.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence is driving the demand for effective treatment options. Advances in medical technology have significantly contributed to the development of novel therapies for short bowel syndrome. These include the development of parenteral nutrition solutions, intestinal transplantation procedures, and the use of intestinal rehabilitation programs. Technological advancements have improved patient outcomes and are expected to drive market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development activities to discover and develop new treatment options for short bowel syndrome. These efforts aim to improve the quality of life for patients and address the unmet medical needs in this field. Hence, such aspects are expected to boost the expansion of the global short bowel syndrome market during the forecast period.

Short Bowel Syndrome Market

Global Short Bowel Syndrome Market – Overview

The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Global Short Bowel Syndrome Market

Growth Drivers

Increasing Prevalence of Short Bowel Syndrome

The global short bowel syndrome (SBS) market is experiencing significant growth, primarily driven by the increasing prevalence of this condition. SBS is becoming more common due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions that result in the removal or dysfunction of a significant portion of the small intestine. This rising prevalence creates a greater demand for effective treatment options, leading to the growth of the global Short Bowel Syndrome market. Pharmaceutical companies, medical device manufacturers, and research organizations are actively investing in research and development activities to discover new therapies and address the unmet medical needs in this field.

Restraints

High Cost of SBS Treatment

The high cost associated with Short Bowel Syndrome (SBS) treatment is a significant restraint on the growth of the global market. Managing SBS requires a combination of pharmacological therapies, parenteral nutrition solutions, medical devices, and potentially surgical interventions, all of which can be expensive. The cost of these treatments, including medications, specialized nutrition support, and medical devices, can pose a financial burden on patients and healthcare systems. The high cost of SBS treatment limits access to care and hinders market growth, particularly in regions with limited healthcare resources or where reimbursement coverage is insufficient. Finding cost-effective solutions and improving affordability are crucial for overcoming this challenge and promoting market expansion.

Impact of COVID-19 on Global Short Bowel Syndrome Market

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients’ access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market

Segmental Coverage

Global Short Bowel Syndrome Market – By Type

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Short Bowel Syndrome Market Size

Global Short Bowel Syndrome Market – By Distribution Channel

Based on distribution channel, the global short bowel syndrome market is bifurcated into Hospital Pharmacies and Retail Pharmacies segments. The retail pharmacies segment holds a higher market share by distribution channel due to their convenience and accessibility. With widespread distribution, they offer easy access to medications and supplies for SBS patients. Retail pharmacies have established networks, enabling efficient prescription fulfillment and insurance handling. Additional services like home delivery and medication synchronization enhance the patient experience and adherence. They play a vital role in raising awareness through community outreach and educational initiatives. Retail pharmacies' convenience, accessibility, established networks, and value-added services position them as the preferred channel for SBS patients, contributing to their high market share in the global market.

Short Bowel Syndrome Market Share

Global Short Bowel Syndrome Market – By Region

The in-depth research report on the global short bowel syndrome market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest market share and is projected to maintain its dominance over the forecast period. This is primarily due to the region's high prevalence of gastrointestinal disorders, including Short Bowel Syndrome (SBS). Additionally, North America benefits from advanced healthcare infrastructure, well-established regulatory frameworks, robust reimbursement systems, and a strong focus on research and development. Higher healthcare expenditure per capita and a well-developed network of specialty clinics and hospitals further contribute to North America's major market share. These factors collectively position the region as a leading market for SBS treatments and therapies.

Competitive Landscape

Major players operating in the global short bowel syndrome market include Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Development

In October 2022 - VectivBio Holding AG announced the release of positive interim data from the company's Phase 2 study that evaluated the safety, pharmacokinetics, and efficacy of apraglutide, a GLP-2 agonist, in adult patients with Short Bowel Syndrome.
In June 2022 - 9 Meters Biopharma, Inc., a company headquartered in the United States, announced positive outcomes from a phase 2 clinical trial evaluating the effectiveness of Vurolenatide in the treatment of short bowel syndrome.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period– 2023–2029
Facts Covered	Revenue in USD Million
Market Coverage	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/ Service Segmentation	Type, Distribution Channel, Region
Key Players	Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, Pivot Pharmaceuticals.

By Type

GLP-2
Growth Hormone
Glutamine

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies

By Region

North America
Europe
Asia Pacific (APAC)
Latin America (LATAM)
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Short Bowel Syndrome Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing prevalence of short bowel syndrome
    2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
  2. Restraints
    1. High cost of SBS treatment
    2. Long-term complications of SBS
  3. Opportunities
    1. Development of new SBS drugs and therapies
    2. Partnerships and collaborations with other companies
  4. Challenges
    1. Stringent regulatory requirements
    2. Competition from generic drugs
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Short Bowel Syndrome Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share and Forecast
  1. By Type
    1. GLP-2
    2. Growth Hormone
    3. Glutamine
    4. Others
  2. By Distribution Channel
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Others
  3. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Short Bowel Syndrome Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Type
  2. By Distribution Channel
  3. By Country
    1. United States
      1. By Type
      2. By Distribution Channel
    2. Canada
      1. By Type
      2. By Distribution Channel
Europe Short Bowel Syndrome Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Type
  2. By Distribution Channel
  3. By Country
    1. Germany
      1. By Type
      2. By Distribution Channel
    2. United Kingdom
      1. By Type
      2. By Distribution Channel
    3. Italy
      1. By Type
      2. By Distribution Channel
    4. France
      1. By Type
      2. By Distribution Channel
    5. Spain
      1. By Type
      2. By Distribution Channel
    6. Belgium
      1. By Type
      2. By Distribution Channel
    7. Russia
      1. By Type
      2. By Distribution Channel
    8. Rest of Europe
      1. By Type
      2. By Distribution Channel
Asia Pacific Short Bowel Syndrome Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Type
  2. By Distribution Channel
  3. By Country
    1. China
      1. By Type
      2. By Distribution Channel
    2. India
      1. By Type
      2. By Distribution Channel
    3. Japan
      1. By Type
      2. By Distribution Channel
    4. South Korea
      1. By Type
      2. By Distribution Channel
    5. Australia & New Zealand
      1. By Type
      2. By Distribution Channel
    6. Indonesia
      1. By Type
      2. By Distribution Channel
    7. Malaysia
      1. By Type
      2. By Distribution Channel
    8. Singapore
      1. By Type
      2. By Distribution Channel
    9. Vietnam
      1. By Type
      2. By Distribution Channel
    10. Rest of APAC
      1. By Type
      2. By Distribution Channel
Latin America Short Bowel Syndrome Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Type
  2. By Distribution Channel
  3. By Country
    1. Brazil
      1. By Type
      2. By Distribution Channel
    2. Mexico
      1. By Type
      2. By Distribution Channel
    3. Argentina
      1. By Type
      2. By Distribution Channel
    4. Peru
      1. By Type
      2. By Distribution Channel
    5. Rest of LATAM
      1. By Type
      2. By Distribution Channel
Middle East & Africa Short Bowel Syndrome Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Type
  2. By Distribution Channel
  3. By Country
    1. Saudi Arabia
      1. By Type
      2. By Distribution Channel
    2. UAE
      1. By Type
      2. By Distribution Channel
    3. Qatar
      1. By Type
      2. By Distribution Channel
    4. Kuwait
      1. By Type
      2. By Distribution Channel
    5. South Africa
      1. By Type
      2. By Distribution Channel
    6. Nigeria
      1. By Type
      2. By Distribution Channel
    7. Algeria
      1. By Type
      2. By Distribution Channel
    8. Rest of MEA
      1. By Type
      2. By Distribution Channel
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Short Bowel Syndrome Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Short Bowel Syndrome Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Takeda
2. Emmaus Life Sciences
3. Nutricia (Danone)
4. Merck KGaA
5. GlyPharma Therapeutics
6. Zealand Pharma
7. Sancilio Pharmaceuticals
8. Naia Pharmaceuticals
9. Ardelyx
10. Adocia
11. Aralez Pharmaceuticals
12. Shield Therapeutics
13. OxThera
14. Rhythm Pharmaceuticals
15. Pivot Pharmaceuticals
16. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

Figure 1 Global Short Bowel Syndrome Market Segmentation

Figure 2 Global Short Bowel Syndrome Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 5 Global Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 6 Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 7 Global Short Bowel Syndrome Market Share, By Region, By Value, 2019−2029

Figure 8 North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 9 North America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 10 North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 11 North America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 12 United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 13 United States Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 14 United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 15 Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 16 Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 17 Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 18 Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 19 Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 20 Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 21 Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 22 Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 23 Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 24 Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 25 United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 26 United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 27 United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 28 Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 29 Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 30 Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 31 France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 32 France Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 33 France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 34 Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 35 Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 36 Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 37 Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 38 Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 39 Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 40 Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 41 Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019−2029

Figure 42 Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 43 The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 44 The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 45 The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019−2029

Figure 46 The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 47 China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 48 China Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 49 China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 50 India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 51 India Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 52 India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 53 Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 54 Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 55 Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 56 South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 57 South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 58 South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 59 Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 60 Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 61 Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 62 Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 63 Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 64 Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 65 Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 66 Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 67 Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 68 Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 69 Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 70 Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 71 Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 72 Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 73 Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 74 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 75 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 76 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 77 Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 78 Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 79 Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 80 Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 81 Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 82 Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 83 Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 84 Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 85 Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 86 Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 87 Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 88 Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 89 Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 90 Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 91 Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 92 Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 93 Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 94 Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019−2029

Figure 95 Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 96 The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 97 The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 98 The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 99 The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 100 Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 101 Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 102 Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 103 UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 104 UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 105 UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 106 Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 107 Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 108 Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 109 Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 110 Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 111 Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 112 Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 113 Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 114 Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 115 South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 116 South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 117 South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 118 Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 119 Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 120 Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 121 Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 122 Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 123 Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 124 Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 125 Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 126 Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 127 Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 128 Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 129 Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 130 Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 131 Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 132 Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 133 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 134 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 135 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Tables

Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019−2029

Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 10 Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 11 Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 12 Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 13 Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 14 Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 15 Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 16 United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 17 United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 18 Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 19 Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 20 France Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 21 France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 22 Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 23 Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 24 Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 25 Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 26 Rest of Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 27 Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 28 The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 29 The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 30 The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 31 China Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 32 China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 33 India Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 34 India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 35 Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 36 Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 37 South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 38 South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 39 Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 40 Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 41 Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 42 Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 43 Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 44 Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 45 Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 46 Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 47 Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 48 Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 49 Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 50 Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 51 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 52 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 53 Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 54 Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 55 Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 56 Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 57 Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 58 Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 59 Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 60 Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 61 Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 62 Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 63 Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 64 Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 65 Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 66 The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 67 The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 68 Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 69 Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 70 UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 71 UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 72 Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 73 Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 74 Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 75 Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 76 Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 77 Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 78 South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 79 South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 80 Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 81 Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 82 Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 83 Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 84 Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 85 Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 86 Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 87 Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 88 Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 89 Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 90 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 91 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 92 Takeda Company Overview

Table 93 Takeda Financial Overview

Table 94 Emmaus Life Sciences Company Overview

Table 95 Emmaus Life Sciences Financial Overview

Table 96 Nutricia (Danone) Company Overview

Table 97 Nutricia (Danone) Financial Overview

Table 98 Merck KGaA Company Overview

Table 99 Merck KGaA Financial Overview

Table 100 GlyPharma Therapeutics Company Overview

Table 101 GlyPharma Therapeutics Financial Overview

Table 102 Zealand Pharma Company Overview

Table 103 Zealand Pharma Financial Overview

Table 104 Sancilio Pharmaceuticals Company Overview

Table 105 Sancilio Pharmaceuticals Financial Overview

Table 106 Naia Pharmaceuticals Company Overview

Table 107 Naia Pharmaceuticals Financial Overview

Table 108 Ardelyx Company Overview

Table 109 Ardelyx Financial Overview

Table 110 Adocia Company Overview

Table 111 Adocia Financial Overview

Table 112 Aralez Pharmaceuticals Company Overview

Table 113 Aralez Pharmaceuticals Financial Overview

Table 114 Pivot Pharmaceuticals Company Overview

Table 115 Pivot Pharmaceuticals Financial Overview

Table 116 Other Prominent Players Company Overview

Table 117 Other Prominent Players Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. Which is a leading segment in the Global Short Bowel Syndrome Market by type?

Ans: The GLP-2 segment is expected to hold the highest market share in the Global Short Bowel Syndrome Market by type.

2. What are the major factors driving the growth of Global Short Bowel Syndrome Market?

Ans: Major factors driving the growth of the Global Short Bowel Syndrome Market include an increasing prevalence of short bowel syndrome and the growing demand for SBS drugs due to the high cost of parenteral nutrition.

3. What is the current market size of Global Short Bowel Syndrome Market?

Ans: Global Short Bowel Syndrome Market size was estimated at USD 828.29 million in 2022.

4. Which distribution channel segment holds a major market share in the Global Short Bowel Syndrome Market?

Ans: The retail pharmacies segment is expected to hold a higher market share in the Global Short Bowel Syndrome Market by distribution channel.

5. Name the key players in Global Short Bowel Syndrome Market.

Ans: Key players in the Global Short Bowel Syndrome Market include Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Short Bowel Syndrome Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

1. Which is a leading segment in the Global Short Bowel Syndrome Market by type?

2. What are the major factors driving the growth of Global Short Bowel Syndrome Market?

3. What is the current market size of Global Short Bowel Syndrome Market?

4. Which distribution channel segment holds a major market share in the Global Short Bowel Syndrome Market?

5. Name the key players in Global Short Bowel Syndrome Market.

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security